Anthony D Elias Selected Research

Anthony D Elias Research Topics

Disease

33	Breast Neoplasms (Breast Cancer) 12/2021 - 05/2006
14	Neoplasms (Cancer) 01/2020 - 04/2008
7	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 07/2009
4	Pathologic Complete Response 12/2021 - 01/2020
4	Triple Negative Breast Neoplasms 12/2021 - 07/2016
2	Residual Neoplasm 11/2021 - 07/2016
2	Disease Progression 01/2018 - 09/2012
2	Febrile Neutropenia 11/2016 - 07/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2002 - 01/2002
1	Synovial Sarcoma (Synovioma) 01/2022
1	Myxoid Liposarcoma 01/2022
1	Hyperglycemia 10/2021
1	Osteonecrosis (Kienbock's Disease) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 08/2017
1	Hodgkin Disease (Hodgkin's Disease) 12/2016
1	Nausea 07/2016
1	Neutropenia 07/2016
1	Vomiting 07/2016
1	Mucositis 07/2016
1	Carcinoma (Carcinomatosis) 06/2013
1	Neurofibrosarcoma (MPNST) 07/2009
1	Hemangiosarcoma (Angiosarcoma) 07/2009

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 12/2021 - 12/2008
6	Estrogens (Estrogen)FDA Link 01/2020 - 12/2008
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2016
4	Estrogen ReceptorsIBA 01/2018 - 12/2008
3	Pharmaceutical PreparationsIBA 10/2021 - 07/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 07/2016
3	Tamoxifen FDA LinkGeneric 04/2017 - 12/2008
3	Trastuzumab (Herceptin)FDA Link 07/2016 - 04/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 10/2021
2	Gemcitabine FDA Link 01/2021 - 04/2010
2	Docetaxel (Taxotere)FDA Link 01/2021 - 05/2006
2	RNA (Ribonucleic Acid)IBA 10/2020 - 04/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 07/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 01/2014
2	enzalutamideIBA 08/2017 - 01/2014
2	AndrogensIBA 08/2017 - 01/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2017 - 12/2010
2	exemestane (Aromasin)FDA Link 08/2017 - 12/2008
2	AnthracyclinesIBA 07/2016 - 04/2008
2	Tyrosine Kinase InhibitorsIBA 07/2015 - 04/2008
2	taxaneIBA 04/2010 - 04/2008
1	B7-H1 AntigenIBA 01/2022
1	atezolizumabIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	durvalumabIBA 12/2021
1	olaparibIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	ganitumabIBA 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	pazopanib FDA Link 01/2021
1	Small Cytoplasmic RNAIBA 10/2020
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	Clodronic Acid (Clodronate)IBA 01/2020
1	MK 2206IBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Ibandronic Acid (Boniva)FDA Link 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	ENMD 2076IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2017
1	Fulvestrant (Faslodex)FDA Link 08/2017
1	A-factor (Streptomyces)IBA 04/2017
1	Phenobarbital (Luminal)FDA Link 04/2017
1	Conditioned Culture MediaIBA 04/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	isophosphamide mustard (IPAM)IBA 11/2016
1	olaratumabIBA 07/2016
1	Monoclonal AntibodiesIBA 07/2016
1	Growth Factor ReceptorsIBA 07/2016
1	veliparibIBA 07/2016
1	human ERBB2 proteinIBA 07/2016
1	Carboplatin (JM8)FDA LinkGeneric 07/2016
1	neratinibIBA 07/2016
1	Drug CombinationsIBA 07/2015
1	Lapatinib (GW572016)FDA Link 07/2015
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2014
1	Estrogen Receptor alphaIBA 01/2014
1	bicalutamide (Casodex)FDA LinkGeneric 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Messenger RNA (mRNA)IBA 06/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012
1	AngiozymeIBA 09/2012
1	Pemetrexed (MTA)FDA Link 04/2010
1	Taxoids (Taxanes)IBA 04/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2009
1	Sorafenib (BAY 43-9006)FDA Link 07/2009

Therapy/Procedure

29	Therapeutics 01/2022 - 01/2002
13	Drug Therapy (Chemotherapy) 11/2021 - 01/2002
7	Neoadjuvant Therapy 12/2021 - 07/2016
6	Radiotherapy 01/2017 - 09/2002
3	Biological Therapy 03/2016 - 04/2014
1	Investigational Therapies (Experimental Therapy) 11/2021
1	Immunotherapy 10/2018
1	Chemoprevention 12/2016